Viemed Healthcare (VMD) Competitors

$9.70 +0.22 (+2.32%)

Closing price 04:00 PM Eastern

Extended Trading

$9.70 0.00 (-0.05%)

As of 04:34 PM Eastern

VMD vs. AVAH, PGNY, ARDT, VRDN, and CDNA

Should you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include Aveanna Healthcare (AVAH), Progyny (PGNY), Ardent Health (ARDT), Viridian Therapeutics (VRDN), and CareDx (CDNA). These companies are all part of the "healthcare" industry.

How does Viemed Healthcare compare to Aveanna Healthcare?

Viemed Healthcare (NASDAQ:VMD) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

: Aveanna Healthcare has a net margin of 9.25% compared to Viemed Healthcare's net margin of 5.53%. Aveanna Healthcare's return on equity of 481.69% beat Viemed Healthcare's return on equity.
Company Net Margins Return on Equity Return on Assets
Viemed Healthcare 5.53% 10.72% 7.82%
Aveanna Healthcare 9.25% 481.69% 6.08%
: Aveanna Healthcare has a consensus price target of $10.25, indicating a potential upside of 58.42%. Given Aveanna Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Aveanna Healthcare is more favorable than Viemed Healthcare.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Aveanna Healthcare
0 Sell rating(s)

6 Hold rating(s)

4 Buy rating(s)

1 Strong Buy rating(s)
2.55
: Aveanna Healthcare has higher revenue and earnings than Viemed Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Viemed Healthcare $270.28M 1.38 $14.93M $0.37 26.22
Aveanna Healthcare $2.43B 0.58 $225.03M $1.02 6.34
: In the previous week, Aveanna Healthcare's average media sentiment score of 0.51 beat Viemed Healthcare's score of 0.00 indicating that Aveanna Healthcare is being referred to more favorably in the news media.
Company Overall Sentiment
Viemed Healthcare Neutral
Aveanna Healthcare Positive
: Viemed Healthcare has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500.
: 74.2% of Viemed Healthcare shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	5.53%	10.72%	7.82%
Aveanna Healthcare	9.25%	481.69%	6.08%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aveanna Healthcare	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.55

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.38	$14.93M	$0.37	26.22
Aveanna Healthcare	$2.43B	0.58	$225.03M	$1.02	6.34

Company	Overall Sentiment
Viemed Healthcare	Neutral
Aveanna Healthcare	Positive

Summary

Aveanna Healthcare beats Viemed Healthcare on 12 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Progyny?

Progyny (NASDAQ:PGNY) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

: 94.9% of Progyny shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 9.9% of Progyny shares are held by insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: Viemed Healthcare has a net margin of 5.53% compared to Progyny's net margin of 4.54%. Progyny's return on equity of 11.37% beat Viemed Healthcare's return on equity.
Company Net Margins Return on Equity Return on Assets
Progyny 4.54% 11.37% 7.73%
Viemed Healthcare 5.53% 10.72% 7.82%
: Progyny has higher revenue and earnings than Viemed Healthcare. Viemed Healthcare is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Progyny $1.29B 1.15 $58.52M $0.65 29.20
Viemed Healthcare $270.28M 1.38 $14.93M $0.37 26.22
: Progyny presently has a consensus price target of $27.91, indicating a potential upside of 47.04%. Given Progyny's stronger consensus rating and higher possible upside, research analysts clearly believe Progyny is more favorable than Viemed Healthcare.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny
0 Sell rating(s)
4 Hold rating(s)

9 Buy rating(s)

0 Strong Buy rating(s)
2.69
Viemed Healthcare
0 Sell rating(s)

2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Progyny has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500.
: In the previous week, Progyny had 2 more articles in the media than Viemed Healthcare. MarketBeat recorded 2 mentions for Progyny and 0 mentions for Viemed Healthcare. Progyny's average media sentiment score of 0.95 beat Viemed Healthcare's score of 0.00 indicating that Progyny is being referred to more favorably in the media.
Company Overall Sentiment
Progyny Positive
Viemed Healthcare Neutral

Company	Net Margins	Return on Equity	Return on Assets
Progyny	4.54%	11.37%	7.73%
Viemed Healthcare	5.53%	10.72%	7.82%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Progyny	$1.29B	1.15	$58.52M	$0.65	29.20
Viemed Healthcare	$270.28M	1.38	$14.93M	$0.37	26.22

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Progyny	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.69
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Overall Sentiment
Progyny	Positive
Viemed Healthcare	Neutral

Summary

Progyny beats Viemed Healthcare on 11 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Ardent Health?

Viemed Healthcare (NASDAQ:VMD) and Ardent Health (NYSE:ARDT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

: Ardent Health has higher revenue and earnings than Viemed Healthcare. Ardent Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Viemed Healthcare $270.28M 1.38 $14.93M $0.37 26.22
Ardent Health $6.32B 0.23 $135.81M $0.96 10.55
: Viemed Healthcare has a net margin of 5.53% compared to Ardent Health's net margin of 2.15%. Ardent Health's return on equity of 14.30% beat Viemed Healthcare's return on equity.
Company Net Margins Return on Equity Return on Assets
Viemed Healthcare 5.53% 10.72% 7.82%
Ardent Health 2.15% 14.30% 4.58%
: In the previous week, Ardent Health had 5 more articles in the media than Viemed Healthcare. MarketBeat recorded 5 mentions for Ardent Health and 0 mentions for Viemed Healthcare. Ardent Health's average media sentiment score of 0.55 beat Viemed Healthcare's score of 0.00 indicating that Ardent Health is being referred to more favorably in the news media.
Company Overall Sentiment
Viemed Healthcare Neutral
Ardent Health Positive
: Viemed Healthcare has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Comparatively, Ardent Health has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500.
: Ardent Health has a consensus price target of $14.25, indicating a potential upside of 40.71%. Given Ardent Health's stronger consensus rating and higher possible upside, analysts clearly believe Ardent Health is more favorable than Viemed Healthcare.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Ardent Health
2 Sell rating(s)

5 Hold rating(s)

7 Buy rating(s)

0 Strong Buy rating(s)
2.36
: 74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 1.9% of Ardent Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.38	$14.93M	$0.37	26.22
Ardent Health	$6.32B	0.23	$135.81M	$0.96	10.55

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	5.53%	10.72%	7.82%
Ardent Health	2.15%	14.30%	4.58%

Company	Overall Sentiment
Viemed Healthcare	Neutral
Ardent Health	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Ardent Health beats Viemed Healthcare on 9 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Viridian Therapeutics?

Viemed Healthcare (NASDAQ:VMD) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

: Viemed Healthcare has higher revenue and earnings than Viridian Therapeutics. Viridian Therapeutics is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Viemed Healthcare $270.28M 1.38 $14.93M $0.37 26.22
Viridian Therapeutics $70.85M 27.31 -$342.60M -$3.29 N/A
: Viemed Healthcare has a net margin of 5.53% compared to Viridian Therapeutics' net margin of -483.57%. Viemed Healthcare's return on equity of 10.72% beat Viridian Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Viemed Healthcare 5.53% 10.72% 7.82%
Viridian Therapeutics -483.57% -83.25% -50.38%
: In the previous week, Viridian Therapeutics had 11 more articles in the media than Viemed Healthcare. MarketBeat recorded 11 mentions for Viridian Therapeutics and 0 mentions for Viemed Healthcare. Viridian Therapeutics' average media sentiment score of 0.98 beat Viemed Healthcare's score of 0.00 indicating that Viridian Therapeutics is being referred to more favorably in the news media.
Company Overall Sentiment
Viemed Healthcare Neutral
Viridian Therapeutics Positive
: Viemed Healthcare has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.
: Viridian Therapeutics has a consensus price target of $37.07, suggesting a potential upside of 97.48%. Given Viridian Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Viridian Therapeutics is more favorable than Viemed Healthcare.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Viridian Therapeutics
1 Sell rating(s)

1 Hold rating(s)

13 Buy rating(s)

0 Strong Buy rating(s)
2.80
: 74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 2.4% of Viridian Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.38	$14.93M	$0.37	26.22
Viridian Therapeutics	$70.85M	27.31	-$342.60M	-$3.29	N/A

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	5.53%	10.72%	7.82%
Viridian Therapeutics	-483.57%	-83.25%	-50.38%

Company	Overall Sentiment
Viemed Healthcare	Neutral
Viridian Therapeutics	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Viridian Therapeutics	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Summary

Viemed Healthcare beats Viridian Therapeutics on 10 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to CareDx?

Viemed Healthcare (NASDAQ:VMD) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

: Viemed Healthcare has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Viemed Healthcare $270.28M 1.38 $14.93M $0.37 26.22
CareDx $412.82M 2.59 -$21.35M -$0.16 N/A
: CareDx has a consensus price target of $25.00, suggesting a potential upside of 20.77%. Given CareDx's higher possible upside, analysts clearly believe CareDx is more favorable than Viemed Healthcare.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
CareDx
1 Sell rating(s)

4 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, CareDx had 12 more articles in the media than Viemed Healthcare. MarketBeat recorded 12 mentions for CareDx and 0 mentions for Viemed Healthcare. CareDx's average media sentiment score of 0.44 beat Viemed Healthcare's score of 0.00 indicating that CareDx is being referred to more favorably in the news media.
Company Overall Sentiment
Viemed Healthcare Neutral
CareDx Neutral
: Viemed Healthcare has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, CareDx has a beta of 2.49, indicating that its share price is 149% more volatile than the S&P 500.
: 74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 4.4% of CareDx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Viemed Healthcare has a net margin of 5.53% compared to CareDx's net margin of -2.01%. Viemed Healthcare's return on equity of 10.72% beat CareDx's return on equity.
Company Net Margins Return on Equity Return on Assets
Viemed Healthcare 5.53% 10.72% 7.82%
CareDx -2.01% -2.65% -1.96%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.38	$14.93M	$0.37	26.22
CareDx	$412.82M	2.59	-$21.35M	-$0.16	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Overall Sentiment
Viemed Healthcare	Neutral
CareDx	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	5.53%	10.72%	7.82%
CareDx	-2.01%	-2.65%	-1.96%

Summary

Viemed Healthcare beats CareDx on 8 of the 15 factors compared between the two stocks.

Get Viemed Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VMD vs. The Competition

Export

Metric	Viemed Healthcare	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$373.26M	$8.15B	$6.25B	$11.87B
Dividend Yield	N/A	2.45%	2.73%	5.21%
P/E Ratio	26.22	119.46	29.03	28.47
Price / Sales	1.38	7.43	476.10	60.92
Price / Cash	8.66	17.32	27.62	36.52
Price / Book	2.57	3.53	9.67	6.67
Net Income	$14.93M	$223.69M	$3.55B	$332.53M
7 Day Performance	-3.48%	0.07%	1.75%	2.03%
1 Month Performance	0.73%	10.16%	5.66%	9.23%
1 Year Performance	32.33%	0.93%	34.42%	39.62%

Viemed Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VMD Viemed Healthcare	2.3754 of 5 stars	$9.70 +2.3%	N/A	N/A	$373.26M	$270.28M	26.22	1,382
AVAH Aveanna Healthcare	4.7187 of 5 stars	$6.70 -0.7%	$10.25 +53.0%	N/A	$1.47B	$2.43B	6.57	35,500
PGNY Progyny	4.7717 of 5 stars	$18.38 -0.2%	$27.91 +51.8%	N/A	$1.44B	$1.29B	28.28	310	Upcoming Earnings
ARDT Ardent Health	3.8069 of 5 stars	$9.67 -3.7%	$14.25 +47.4%	N/A	$1.44B	$6.32B	10.07	25,200	News Coverage
VRDN Viridian Therapeutics	3.4629 of 5 stars	$13.61 +0.8%	$37.07 +172.4%	N/A	$1.39B	$70.85M	N/A	50	Earnings Report Gap Up Trading Halted

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VMD) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Viemed Healthcare (VMD) Competitors

VMD vs. AVAH, PGNY, ARDT, VRDN, and CDNA

How does Viemed Healthcare compare to Aveanna Healthcare?

Summary

How does Viemed Healthcare compare to Progyny?

Summary

How does Viemed Healthcare compare to Ardent Health?

Summary

How does Viemed Healthcare compare to Viridian Therapeutics?

Summary

How does Viemed Healthcare compare to CareDx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Viemed Healthcare (VMD) Competitors

VMD vs. AVAH, PGNY, ARDT, VRDN, and CDNA

How does Viemed Healthcare compare to Aveanna Healthcare?

Summary

How does Viemed Healthcare compare to Progyny?

Summary

How does Viemed Healthcare compare to Ardent Health?

Summary

How does Viemed Healthcare compare to Viridian Therapeutics?

Summary

How does Viemed Healthcare compare to CareDx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools